Typicality: | 0.457 |
Saliency: | 0.484 |
by developing innovative therapeutics | 22 | manner |
ligand → create → cash flows | 22 |
negative | neutral | positive |
0.202 | 0.485 | 0.312 |
Raw frequency | 22 |
Normalized frequency | 0.484 |
Modifier score | 0.500 |
Perplexity | 249.862 |